Combined subcutaneous GHRP-2 + GHRH infusion sustained pulsatile GH secretion and elevated IGF-1 and IGFBP-3 in healthy older adults with gender-specific synergy — women showed greater response than men.
Sustained without fadeCombined GHRP-2 + GHRH maintained elevated pulsatile GH and IGF-1 without desensitization in older adults — sustainable anti-aging hormone restoration
What the researchers found
Combined SC GHRP-2 + GHRH infusion sustainably elevated pulsatile GH, IGF-1, and IGFBP-3 in healthy older adults without desensitization, with synergy exceeding individual effects and women showing greater response than men.
Why it matters
Age-related GH decline affects millions. A sustained, synergistic peptide combination that restores youthful GH patterns without desensitization could transform anti-aging endocrinology.
How the study worked
Clinical trial in healthy older adults. SC infusion of combined GHRP-2 + GHRH. GH profiling (deconvolution analysis), IGF-1, IGFBP-3 measured. Gender comparison. Synergy versus individual peptide effects assessed.
What this study cannot tell us
Short-term SC infusion study. Long-term chronic infusion effects need assessment. SC infusion is less practical than oral or daily injection dosing.
How to read the evidence
Strong evidence from a well-designed clinical trial with intensive hormonal profiling and gender comparison in the target elderly population.
When this study was published
Published in 2004. Combined GHRP + GHRH remains the gold standard for research on restoring the aging GH axis.
The bigger picture
The combination of GHRP + GHRH is the most effective physiological approach to restoring GH secretion in aging — hitting both the accelerator and releasing the brake simultaneously.
Questions still open
- Can the synergistic effect be achieved with intermittent dosing?
- Why do women respond more than men?
- Could this combination prevent age-related muscle and bone loss?
Common questions
Can GH decline with aging be reversed?
Do men and women respond differently?
Read the original research
Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women.
The Journal of clinical endocrinology and metabolism, 89(5), 2290-300
Citation
Bowers, Cyril Y; Granda, Ramona; Mohan, Subburaman; Kuipers, Jonathan; Baylink, David; Veldhuis, Johannes D. (2004). Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women.. The Journal of clinical endocrinology and metabolism, 89(5), 2290-300.